Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Industry News
3/11/2024
Johnson & Johnson Completes Acquisition of Ambrx
3/7/2024
Novo Nordisk Expects Chinese Approval for Weight Loss Drug Wegovy This...
3/6/2024
Biopharma Delegates Advocate for Policy Reforms During China's Two Ses...
3/3/2024
AstraZeneca Signs $475 Million Deal for Innovative Drug Facility in Wu...
3/3/2024
Bitterroot Bio and Biotheus Enter Research Partnership to Develop Bisp...
3/3/2024
Mabwell Out-Licenses Ex-China Rights of Rare Disease Drug to Disc Medi...
3/3/2024
Haihe and Taiho Enter Exclusive License Deal for Anticancer Gumarontin...
3/1/2024
Financial-related Company News Digest (February 2024)
2/28/2024
BeiGene Defies Biotech Winter with Workforce Expansion and Sales Surge...
2/28/2024
AstraZeneca Chooses Shanghai as Fifth Global Strategic Center, Reinfor...
2/26/2024
BeiGene Ends Partnership with Shoreline in Cell Therapy Venture
2/26/2024
Beijing Haidian District Unveils Measures to Boost High-Quality Develo...
2/26/2024
Danone Report Robust China Growth, Fueled by Infant and Medical Nutri...
2/26/2024
Mabwell Terminates Licensing Deals with Yangtze River Pharma for Two C...
2/26/2024
Despite Challenges, German MNCs Plans Increased Investments in China
2/26/2024
Nhwa Pharma Licenses China Commericialization Rights of Teva's AUSTEDO...
2/22/2024
Domestic Drugmakers Showcased Remarkable Innovation and Global Expansi...
2/21/2024
Sinopharm Offers to Take HK-listed China-TCM Private in Nearly US$3B D...
2/20/2024
AlphaGen and ARTBIO Announce Strategic Deal for the Development and Co...
2/19/2024
Everest Ends Covid-19 Vaccine Deal With Canada's Providence
2/19/2024
IMD: China Is Becoming Tech, Pharma Powerhouse
2/19/2024
Gilead and Biocytogen Strike a Multi-Target Antibody Collaboration Dea...
2/15/2024
LianBio Completes Strategic Review for Winding Down of Its Operations
2/8/2024
China Drug Sales Performance of Top Seven MNC Pharma Cos in 2023
2/7/2024
I-Mab to Divest China Operations and Become a US-Focused Biotech
2/6/2024
Luye Pharma Collaborates with Myung In Pharm in Advancing Treatment f...
2/6/2024
Potential Impact of the US Bill on Wuxi AppTec and Its Western Drugmak...
2/5/2024
Eisai Encouraged by Market Potential of Its Alzheimer's Drug Leqembi i...
2/5/2024
U.S. Congress Postpones Legislation Targeting Chinese Biotech Firms
2/5/2024
CMS Licenses Greater China Rights of First-line Phosphate-lowering Dru...
Page:
2
/
13
Total number of articles:
372
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit